The price of Edwards Lifesciences Corp (NYSE:EW) shares last traded on Wall Street fell -1.96% to $91.20.
EW stock price is now 4.54% away from the 50-day moving average and 15.70% away from the 200-day moving average. The market capitalization of the company currently stands at $54.84B.
On February 02, 2024, Wells Fargo Upgraded its previous ‘Equal Weight’ rating to ‘Overweight’ on the stock keeping its target price maintained at $94, while ‘Evercore ISI’ rates the stock as ‘In-line’
In other news, MUSSALLEM MICHAEL A, Director sold 29,350 shares of the company’s stock on Apr 04 ’24. The stock was sold for $2,712,418 at an average price of $92.42. Upon completion of the transaction, the Director now directly owns 4,486 shares in the company, valued at $0.41 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Apr 01 ’24, CVP, Chief Financial Officer Ullem Scott B. sold 7,255 shares of the business’s stock. A total of $688,423 was realized by selling the stock at an average price of $94.89. This leaves the insider owning 19,074 shares of the company worth $1.74 million. A total of 1.58% of the company’s stock is owned by insiders.
During the past 12 months, Edwards Lifesciences Corp has had a low of $60.57 and a high of $96.12. As of last week, the company has a debt-to-equity ratio of 0.10, a current ratio of 3.38, and a quick ratio of 2.40. According to the stock market information, the enterprise value for the company is $53.95B, which is based on a 39.62 price-to-earnings ratio, a 4.24 price-to-earnings-growth ratio, and a beta of 1.08. The fifty day moving average price for EW is $87.24 and a two-hundred day moving average price translates $78.83 for the stock.
The latest earnings results from Edwards Lifesciences Corp (NYSE: EW) was released for Dec, 2023. According to the Medical Devices Company, earnings per share came in at $0.64, inline with analysts’ expectations of $0.64. This compares to $0.65 EPS in the same period last year. The net profit margin was 23.35% and return on equity was 22.52% for EW. The company reported revenue of $1.53 billion for the quarter, compared to $1.35 billion a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 13.78 percent. For the current quarter, analysts expect EW to generate $1.57B in revenue.
